Monte Rosa Therapeutics (GLUE) EPS (Basic) (2020 - 2026)
Monte Rosa Therapeutics (GLUE) posted quarterly EPS (Basic) of -$0.45 for Q1 2026, down 178.15% year-over-year from $0.57 in Q1 2025, and down 25.65% quarter-over-quarter from -$0.35 in Q4 2025.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) EPS (Basic) (2020 - 2026) Analysis & Trends
Monte Rosa Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.45 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 178.15% year-over-year to -$0.45; the TTM figure through Mar 2026 stood at -$1.14 (down 497.77% YoY), while the FY2025 annual figure was -$0.26, up 64.7% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.45, down from -$0.35 in the prior quarter.
- The five-year high for EPS (Basic) was $0.57 in Q1 2025, with the low at -$1.39 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.53 (2024), against an average of -$0.44.
- Peak annual rise in EPS (Basic) reached 207.34% in 2025, while the deepest fall reached 185.37% in 2025.
- Monte Rosa Therapeutics' EPS (Basic) stood at -$0.65 in 2022, then grew by 0.74% to -$0.65 in 2023, then surged by 164.27% to $0.42 in 2024, then tumbled by 185.37% to -$0.35 in 2025, then slipped by 25.65% to -$0.45 in 2026.
- Business Quant data shows GLUE's EPS (Basic) at -$0.45 in Q1 2026, -$0.35 in Q4 2025, and -$0.33 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Monte Rosa Therapeutics | 1.42 Bn | 784.76 Mn | - | -0.43 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.43 |
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | 0.57 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | -0.29 |
| Jun 30, 2024 | -0.43 |
| Mar 31, 2024 | -0.53 |
| Dec 31, 2023 | -0.65 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | -0.71 |
| Mar 31, 2023 | -0.65 |
| Dec 31, 2022 | -0.65 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.52 |
| Dec 31, 2021 | -0.93 |
| Sep 30, 2021 | -0.43 |